• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者尿代谢组学生物标志物差异的可行性研究,以寻找潜在的生物标志物。

Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers.

机构信息

Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Univesità Cattolica del Sacro Cuore, 00168 Rome, Italy.

Unity of Chemistry, Biochemistry and Clinical Molecular Biology, Department of Diagnostic and Laboratory Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

出版信息

Curr Oncol. 2023 May 10;30(5):4904-4921. doi: 10.3390/curroncol30050370.

DOI:10.3390/curroncol30050370
PMID:37232828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10217291/
Abstract

Prostate cancer (PCa) continues to be the second most common malignant tumour and the main cause of oncological death in men. Investigating endogenous volatile organic metabolites (VOMs) produced by various metabolic pathways is emerging as a novel, effective, and non-invasive source of information to establish the volatilomic biosignature of PCa. In this study, headspace solid-phase microextraction combined with gas chromatography-mass spectrometry (HS-SPME/GC-MS) was used to establish the urine volatilomic profile of PCa and identify VOMs that can discriminate between the two investigated groups. This non-invasive approach was applied to oncological patients (PCa group, = 26) and cancer-free individuals (control group, = 30), retrieving a total of 147 VOMs from various chemical families. This included terpenes, norisoprenoid, sesquiterpenes, phenolic, sulphur and furanic compounds, ketones, alcohols, esters, aldehydes, carboxylic acid, benzene and naphthalene derivatives, hydrocarbons, and heterocyclic hydrocarbons. The data matrix was subjected to multivariate analysis, namely partial least-squares discriminant analysis (PLS-DA). Accordingly, this analysis showed that the group under study presented different volatomic profiles and suggested potential PCa biomarkers. Nevertheless, a larger cohort of samples is required to boost the predictability and accuracy of the statistical models developed.

摘要

前列腺癌(PCa)仍然是第二常见的恶性肿瘤,也是男性癌症死亡的主要原因。研究各种代谢途径产生的内源性挥发性有机代谢物(VOMs),作为一种新的、有效的、非侵入性的信息来源,以建立 PCa 的挥发组生物标志物,正变得越来越重要。在本研究中,采用顶空固相微萃取结合气相色谱-质谱法(HS-SPME/GC-MS)来建立 PCa 的尿液挥发组图谱,并鉴定出能够区分两组研究对象的 VOMs。这种非侵入性的方法应用于肿瘤患者(PCa 组,n=26)和无癌症个体(对照组,n=30),从各种化学家族中提取了总共 147 种 VOMs。其中包括萜类、异戊二烯、倍半萜、酚类、硫和呋喃化合物、酮类、醇类、酯类、醛类、羧酸、苯和萘衍生物、碳氢化合物和杂环碳氢化合物。将数据矩阵进行多元分析,即偏最小二乘判别分析(PLS-DA)。因此,该分析表明,所研究的组具有不同的挥发组图谱,并提示了潜在的 PCa 生物标志物。然而,需要更大的样本队列来提高所开发统计模型的可预测性和准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/2617a5b5cfc7/curroncol-30-00370-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/eccea6f12f8e/curroncol-30-00370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/3dcfee911130/curroncol-30-00370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/b29e848534cc/curroncol-30-00370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/e072c6ca8a14/curroncol-30-00370-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/8ae33a4a65ad/curroncol-30-00370-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/238133240d5e/curroncol-30-00370-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/2617a5b5cfc7/curroncol-30-00370-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/eccea6f12f8e/curroncol-30-00370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/3dcfee911130/curroncol-30-00370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/b29e848534cc/curroncol-30-00370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/e072c6ca8a14/curroncol-30-00370-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/8ae33a4a65ad/curroncol-30-00370-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/238133240d5e/curroncol-30-00370-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/10217291/2617a5b5cfc7/curroncol-30-00370-g007.jpg

相似文献

1
Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers.前列腺癌患者尿代谢组学生物标志物差异的可行性研究,以寻找潜在的生物标志物。
Curr Oncol. 2023 May 10;30(5):4904-4921. doi: 10.3390/curroncol30050370.
2
Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.固相微萃取结合气相色谱-质谱法研究尿液中挥发性有机代谢物作为潜在的癌症生物标志物。
Br J Cancer. 2011 Dec 6;105(12):1894-904. doi: 10.1038/bjc.2011.437. Epub 2011 Nov 15.
3
Exploring the potential of needle trap microextraction combined with chromatographic and statistical data to discriminate different types of cancer based on urinary volatomic biosignature.基于尿液挥发性生物标志物,探索针阱微萃取与色谱和统计数据相结合来区分不同类型癌症的潜力。
Anal Chim Acta. 2018 Sep 6;1023:53-63. doi: 10.1016/j.aca.2018.04.027. Epub 2018 Apr 24.
4
Investigation of volatile organic metabolites in lung cancer pleural effusions by solid-phase microextraction and gas chromatography/mass spectrometry.固相微萃取-气相色谱/质谱联用分析肺癌胸腔积液中的挥发性有机代谢产物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jan 15;945-946:53-9. doi: 10.1016/j.jchromb.2013.11.038. Epub 2013 Nov 25.
5
Spices Volatilomic Fingerprinting-A Comprehensive Approach to Explore Its Authentication and Bioactive Properties.香料挥发物指纹图谱分析——一种探索其鉴定和生物活性特性的综合方法。
Molecules. 2022 Sep 28;27(19):6403. doi: 10.3390/molecules27196403.
6
Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.采用中心复合设计优化固相微萃取,建立尿液挥发性表达:乳腺癌的初步研究。
Metabolomics. 2019 Apr 17;15(4):64. doi: 10.1007/s11306-019-1525-2.
7
Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers.挥发性代谢组学:检测潜在前列腺癌生物标志物的一条新兴且有前景的途径。
Cancers (Basel). 2022 Aug 17;14(16):3982. doi: 10.3390/cancers14163982.
8
Relationship between Volatile Composition and Bioactive Potential of Vegetables and Fruits of Regular Consumption-An Integrative Approach.常规食用蔬菜和水果的挥发性成分与生物活性潜力之间的关系——一种综合方法。
Molecules. 2021 Jun 15;26(12):3653. doi: 10.3390/molecules26123653.
9
Exploring the potential of NTME/GC-MS, in the establishment of urinary volatomic profiles. Lung cancer patients as case study.探讨 NTME/GC-MS 在建立尿液挥发性图谱中的潜力。以肺癌患者为案例研究。
Sci Rep. 2018 Aug 30;8(1):13113. doi: 10.1038/s41598-018-31380-y.
10
Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.建立顶空固相微萃取-气相色谱-高分辨质谱法分析尿液中挥发性有机化合物的方法:在乳腺癌生物标志物发现中的应用。
Clin Chim Acta. 2023 Feb 1;540:117236. doi: 10.1016/j.cca.2023.117236. Epub 2023 Jan 27.

引用本文的文献

1
Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine.尿液中挥发性有机化合物对肿瘤的非侵入性检测
Biomedicines. 2025 Jan 6;13(1):109. doi: 10.3390/biomedicines13010109.
2
Potential urinary volatile organic compounds as screening markers in cancer - a review.潜在的尿液挥发性有机化合物作为癌症筛查标志物——综述
Front Oncol. 2024 Nov 25;14:1448760. doi: 10.3389/fonc.2024.1448760. eCollection 2024.
3
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.

本文引用的文献

1
Underlying Features of Prostate Cancer-Statistics, Risk Factors, and Emerging Methods for Its Diagnosis.前列腺癌的基本特征-统计数据、风险因素和新的诊断方法。
Curr Oncol. 2023 Feb 15;30(2):2300-2321. doi: 10.3390/curroncol30020178.
2
Identification of phenol 2,2-methylene bis, 6 [1,1-D] as breath biomarker of hepatocellular carcinoma (HCC) patients and its electrochemical sensing: E-nose biosensor for HCC.鉴定2,2-亚甲基双(6-[1,1-D])苯酚作为肝细胞癌(HCC)患者的呼吸生物标志物及其电化学传感:用于HCC的电子鼻生物传感器。
Anal Chim Acta. 2023 Feb 15;1242:340752. doi: 10.1016/j.aca.2022.340752. Epub 2022 Dec 28.
3
通过尿液代谢组学特征预测具有临床意义的前列腺癌:一项大规模验证研究。
J Transl Med. 2023 Oct 11;21(1):714. doi: 10.1186/s12967-023-04424-9.
Potential role of volatile organic compound breath testing in the Australasian colorectal cancer pathway.
挥发性有机化合物呼气检测在澳大拉西亚结直肠癌通路中的潜在作用。
ANZ J Surg. 2023 May;93(5):1159-1161. doi: 10.1111/ans.18195. Epub 2023 Jan 11.
4
A Complete Pipeline for Untargeted Urinary Volatolomic Profiling with Sorptive Extraction and Dual Polar and Nonpolar Column Methodologies Coupled with Gas Chromatography Time-of-Flight Mass Spectrometry.采用吸附萃取和双极性及非极性柱方法与气相色谱飞行时间质谱联用的非靶向性尿挥发组学分析完整工作流程。
Anal Chem. 2023 Jan 17;95(2):758-765. doi: 10.1021/acs.analchem.2c02873. Epub 2023 Jan 5.
5
Breast cancer detection using volatile compound profiles in exhaled breath via selected ion-flow tube mass spectrometry.采用选择离子流管质谱技术分析呼出气挥发性化合物谱检测乳腺癌。
J Breath Res. 2022 Dec 8;17(1). doi: 10.1088/1752-7163/aca696.
6
Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine.通过分析人体尿液中的挥发性有机化合物 (VOC) 特征来检测乳腺癌。
Sci Rep. 2022 Sep 1;12(1):14873. doi: 10.1038/s41598-022-17795-8.
7
Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers.挥发性代谢组学:检测潜在前列腺癌生物标志物的一条新兴且有前景的途径。
Cancers (Basel). 2022 Aug 17;14(16):3982. doi: 10.3390/cancers14163982.
8
Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.利用呼气中的挥发性有机化合物检测结直肠腺瘤和癌症:改善筛查的原理验证研究。
Clin Transl Gastroenterol. 2022 Nov 1;13(11):e00518. doi: 10.14309/ctg.0000000000000518.
9
Analysis of VOCs in Urine Samples Directed towards of Bladder Cancer Detection.针对膀胱癌检测的尿液样本中 VOCs 分析。
Molecules. 2022 Aug 7;27(15):5023. doi: 10.3390/molecules27155023.
10
Volatolomic urinary profile analysis for diagnosis of the early stage of lung cancer.用于肺癌早期诊断的挥发性尿液成分分析
J Breath Res. 2022 Sep 2;16(4). doi: 10.1088/1752-7163/ac88ec.